By John P. Bilezikian, MD
Location: 5 Wohl Auditorium (Lower Level)
*Please RSVP using the link below by Monday, April 24, 2023 if you plan on attending (In-Person to ensure we can accommodate everyone.
RSVP Link: https://wustl.az1.qualtrics.com/jfe/form/SV_9uc5ZqWKQgjJj4W
About the Speaker:
Dr. Bilezikian, the Dorothy L. and Daniel H. Silberberg Professor of Medicine and Professor of Pharmacology at the College of Physicians & Surgeons, Columbia University is Vice Chair of the Department of Medicine for International Education and Research and Chief, Emeritus, of the Division of Endocrinology. He is Director, Emeritus, of the Metabolic Bone Diseases Program at Columbia University Medical Center.
Dr. Bilezikian’s has served as past president of the ASBMR and ISCD and his major research
interests are related to the clinical investigation of metabolic bone diseases, particularly primary hyperparathyroidism, hypoparathyroidism and osteoporosis. His studies of parathyroid hormone in these disorders with regard to etiology, clinical manifestations, pathophysiology, mechanisms of skeletal involvement, and therapy are known throughout the world as landmark contributions to our knowledge of these disorders. He has been continuously funded by the NIH since 1974. Over 850 publications speak to these active original investigative initiatives as well as his authorship of many reference sources of endocrinology and metabolic bone diseases.